Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
54
days
Investigation of biomarkers for azole antifungal-induced liver injury using primary human hepatocyte spheroids
Authors
Masaki Kumondai; Ayaka Yagi; Masahiro Watanabe; Yanlin Lyu; Ryosuke Segawa; Mayumi Sato; Ryo Tadakuma; Kenji Inoue; Hideki Watanabe; Masahiro Takeda; Yoshiteru Ohshima; Masamitsu Maekawa; Nariyasu ManoShow moreShow less
Affiliations
Department of Pharmaceutical Sciences, Tohoku University Hospital, Aoba-ku, Sendai, Japan; Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Japan; Drug Development Research Laboratories, Kyoto R&D Center, Maruho Co, Ltd, Kita-ku, Osaka, Japan; Head Office for Open Innovation Business Development Strategy, Tohoku University, Aoba-ku, Sendai, JapanShow moreShow less
172
days
Absorption, metabolism, and excretion of single dose oral [14C]camizestrant in healthy human female participants
Authors
Andy Sykes; Zhoupeng Zhang; Jana Skeete; Pradeep Sharma; Stephen Wilkinson; Ryan Bragg; Sasha McClain; Malin Gränfors; Isobel Leddin; Christopher Bailey; Bistra Kirova; Nand Singh; Karthick Vishwanathan; Niresh HariparsadShow moreShow less
Affiliations
Clinical Pharmacology and Quantitative Pharmacology, AstraZeneca, Cambridge, UK; Drug Metabolism and Pharmacokinetics, Oncology R&D, AstraZeneca, Waltham, Massachusetts; Drug Metabolism and Pharmacokinetics, Oncology R&D, AstraZeneca, Cambridge, UK; Early Chemical Development, Pharmaceutical Sciences, AstraZeneca, Cambridge, UK; Late Development, Oncology R&D, AstraZeneca, Gaithersburg, Maryland; Early Product Development and Manufacturing, Pharmaceutical Sciences, AstraZeneca, Gothenburg, Sweden; Late Development, Oncology R&D, AstraZeneca, Cambridge, UK; Integrated Bioanalysis, AstraZeneca, Cambridge, UK; Oncology Patient Safety, Oncology R&D, AstraZeneca, Cambridge, UK; Medical Department, Quotient Sciences, Ruddington, Nottingham, UK; Clinical Pharmacology and Pharmacometrics, AstraZeneca, Waltham, MassachusettsShow moreShow less
134
days
Reduction of secondary 3-keto bile acids by aldo-keto reductase 1C1 and 1C4
Authors
Keith D. Green; Graham K. Thomason; Lindsay C. CzubaShow moreShow less
Affiliations
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KentuckyShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days